News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.

1Bitget UEX Daily | Trump Claims Quick End to Iran Action; Crude Oil Pulls Back from Highs, US Stocks Rebound; Japan's Cryptocurrency Asset Trading Surges (March 10, 2026)2Oracle Q3 Earnings Preview: Limited Performance Boost, Market Seeks Long-Term Optimistic Outlook3Wall Street funneled $540M into US Solana ETFs in Q4: Bloomberg
Flash
13:08
Nvidia will make a "significant" investment in the US AI company Thinking Machines and provide AI chips.PANews March 10 – According to market sources, Nvidia will make a “significant” investment in the American AI startup Thinking Machines and provide AI chips.
13:01
B. Riley gives Strategy and Strive a Buy rating and sets a target priceB. Riley has initiated coverage on Strategy and Strive with a Buy rating, setting target prices at $175 and $12, respectively. The report points out that the decline in bitcoin during 2025-2026 has compressed valuations for financial companies and hindered stock-based bitcoin accumulation. Preferred stock financing and diversified business lines may drive the next stage of growth.
12:54
NIO's William Li: Three all-new models will be launched this year, and five large and mid-to-large SUVs are expected to lay the foundation for annual sales growth.Golden Ten Data reported on March 10 that on March 10, NIO founder, chairman, and CEO William Li stated during the company's Q4 2025 and full-year earnings call that NIO will launch three brand-new models this year. The flagship ES9 executive technology SUV will be launched in the second quarter of this year, a large five-seat SUV based on the new ES8 platform will be launched in the third quarter, and the Ledo L80 will be launched in the second quarter. Together with the Ledo L90 and the hot-selling new ES8, these five mid-to-large and large SUVs are expected to lay a very solid foundation for full-year sales growth this year.
Trending news
MoreNvidia will make a "significant" investment in the US AI company Thinking Machines and provide AI chips.
Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting
News